Sleepwalking through an epidemic - Why social work should wake up to the threat of hepatitis C

British Journal of Social Work

Volumn 34, Issue 6, 2004, Pages 897-906

  Paylor, Ian ^a,c   Orgel, Michael ^b  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b Edinburgh Comm Drug Problem Service   (United Kingdom)

^c LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Drug users; Epidemic; HCV; Injecting

Indexed keywords

EID: 7444228002     PISSN: 00453102     EISSN: None     Source Type: Journal    
DOI: 10.1093/bjsw/bch107     Document Type: Review

References (39)

1. ACMD (1988) AIDS and Drug Misuse, Part 1, Report by Advisory Council on the Misuse of Drugs, HMSO, London.
2. Aldridge, J., Parker, H. and Measham, F. (1999) Drug Trying and Drug Use Across Adolescence, DPAS Paper 1, London, Home Office.
3. Ashton, M. (2003) 'Hepatitis C and needle exchange', Drug and Alcohol Findings, 8, pp. 4-7, 16-17.
4. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. and Houghton, M. (1989) 'Isolation of a CDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome', Science, 224, pp. 359-62.
5. Cook, P. A., McVeigh, J., Patel, A., Syed, Q., Mutton, K. and Bellis, M. A. (2000) Hepatitis C in injecting drug users in the North-West: A multi-agency study, Liverpool, John Moores University.
6. Cook, P. A., McVeigh, J., Syed, Q., Mutton, K. and Bellis, M. A. (2001) 'Predictors of hepatitis B and C infection in injecting drug users both in and out of drug treatment', Addiction, 96 (12), pp. 1787-97.
7. Coulshed, V. and Orme, J. (1998) Social Work Practice: An Introduction, 3rd edn, Basingstoke, Palgrave.
8. Crofts, N., Nigro, L., Oman, K., Stevenson, E. and Sherman, J. (1997) 'Methadone maintenance and hepatitis C virus infection among injecting drug users', Addiction, 92 (8), pp. 999-1005.
9. Darwish, M. A., Raouf, T. A., Rushdy, P., Constantine, N. T., Rao, M. R. and Edelman, R. (1993) 'Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors', American Journal of Tropical Medicine and Hygiene, 49, pp. 440-7.
10. Davis, G. L. and Lau, J. Y. (1997) 'Factors predictive of a beneficial response to therapy to hepatitis C', Hepatology, 26, pp. 122S-127S.
11. Di Bisceglie, A. M., Hutchinson, J. and Rice, C. M. (2002) 'New therapeutic strategies for hepatitis', Hepatology, 35 (1), pp. 224-31.
12. Department of Health (1992) The Health of Our Nation, London, HMSO.
13. Department of Health (2002) Hepatitis C strategy for England, 2331 4.2 NS, London, Department of Health.
14. Dusheiko, G. et al. (1994) 'Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease', Hepatology, 19, pp. 13-18.
15. EMCDDA (2001) Annual Report on the State of the Drug Problem in the European Union, Lisbon, European Monitoring Centre for Drug and Drug Addiction.
16. Fountain, J. and Howes, S. (2001) Rough Sleeping, Substance Use and Service Provision in London, London, National Addiction Centre.
17. Goldberg, D., Cameron, S. and McMenamin, J. (1998) 'Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high', Communicable Disease and Public Health, 1, pp. 95-7.
18. Gordan, S. C., Elloway, R. S., Long, J. C. and Dmuchowski, C. F. (1993) 'The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use', Hepatology, 18, pp. 1338-43.
19. Hanley, J. P., Jarvis, L. M., Andrew, J., Dennis, R., Hayes, P. C., Piris, J., Lee, R., Simmonds, P. and Ludlam, C. A. (1996) 'Interferon treatment for chronic hepatitis C infection in hemophiliacs-influence of virus load, genotype, and liver pathology on response', Blood, 87, pp. 1704-9.
20. Humphries, P. (2002) 'An explosive situation', Guardian, 6 March.
21. Hunter, G. M., Donoghoe, M. C., Stimson, G. V., Rhodes, T. and Chalmers, C. P. (1995) 'Changes in the injecting risk behaviour of injecting drug users in London 1991-1993', AIDS, 9 (5), pp. 493-501.
22. Hutchinson, S. J. Taylor, A., Goldberg, D. L. and Gruer, L. (2000) 'Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and prevention of blood-borne viruses', Addiction, 95 (6), pp. 931-40.
23. Jarman Centre (2000) A Practical Guide to Hepatitis C, CommuniCare NHS Trust.
24. Jones, A. and Millar, T. (2000) Mortality and Drug Use: Making Sense of Mortality Data, Manchester, Drug Misuse Research Unit University of Manchester.
25. Koyama, T., Tsuda, F., and Ishikawa, K. (1997) 'Antibodies to hepatitis C virus and elevated transaminase levels in a town of hyperendemicity in Iwate', Japan Journal of Gastroenterology and Hepatology, 12, pp. 67-72.
26. Kuo, G., Choo, Q. L. and Alter, H. J. (1989) 'An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis', Science, 224, pp. 362-4.
27. Liang, T. J. (1998) 'Combination therapy for hepatitis C infection' (editorial comment), New England Journal of Medicine, 339, pp. 1549-50.
28. McOmish, F., Chan, S. W. and Dow, B. C. (1993) 'Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities', Transfusion, 33, pp. 7-13.
29. Noone, A., Durante, A. J., Brady, A. R., Majid, F., Swan, A. V., Parry, J. V., Har, G. J., Connell, J. A., Perry, K. R. and Joce, R. E. (1993) 'HIV infection in injecting drug users attending centres in England and Wales 1990-91', AIDS, 7, pp. 1501-7.
30. Orgel, M. and Tibbs, C. (1995) 'Attitudes and knowledge about Hepatitis C in a cohort of methadone maintenance clinic patients', V1 International Conference on the Reduction of Drug-related Harm, Florence, Italy, 26-30 March.
31. Power, R., Hunter, G. M., Jones, S. G. and Donoghue, M. C. (1994) 'The sharing of injecting paraphernalia among injecting drug users', AIDS, 8, pp. 1509-11.
32. Poynard, T., Bedossa, P. and Opolon, P. (1997) 'Natural history of liver fibrosis progression in-patients with chronic hepatitis', Lancet, 349, pp. 825-32.
33. Royal College of Physicians Edinburgh (2004) Final Consensus Statement of Hepatitis C Consensus Conference, Edinburgh, 21st and 22nd April.
34. Saleh, M. G., Pereira, L. M. and Tibbs, C. J. (1994) 'High prevalence of hepatitis C virus in the normal Libyan population', Transactions of the Royal society of Tropical Medicine and Hygiene, 88, pp. 292-4.
35. Simmonds, P. (1995) 'Variability of hepatitis C virus', Hepatology, 21, pp. 570-83.
36. Stark, K., Muller, R., Bienzle, U. and Guggenmoos-Holzmann, I. (1996) 'Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Britain', AIDS, 10, pp. 311-17.
37. Stimson, G. V. (1995) 'AIDS and injecting drug use in the United Kingdom, 1987-1993: The policy response and the prevention of the epidemic', Social Science and Medicine, 41 (5), pp. 699-716.
38. Tibbs, C. J. (1995) 'Methods of transmission of Hepatitis C', Journal of Viral Hepatitis, 2, pp. 13-19.
39. WHO (2000) 'Hepatitis C: Fact sheet 164' available at www.who.int/inf-fs/en/ fact164.html.